当前位置： SCI文献检索 > JOURNAL OF NEUROSURGERY期刊下所有文献 > The effect of a PP2A inhibitor on the nuclear receptor corepressor pathway in glioma.

The effect of a PP2A inhibitor on the nuclear receptor corepressor pathway in glioma.

Abstract：

OBJECT:Nuclear receptor corepressor (N-CoR) forms a complex that maintains neural stem cells in an undifferentiated state through transcriptional repression. Recently, it has been shown that N-CoR is overexpressed in glioblastoma multiforme (GBM) tumor stem cells and has a putative role in maintaining these cells in an undifferentiated immortal state. To determine the effects of disruption of N-CoR complex function by serine/threonine protein phosphatase 2A (PP2A) inhibition on GBM tumor cell differentiation and proliferation, the authors developed and investigated a competitive small molecule inhibitor (LB1) of PP2A in GBM. METHODS:The authors investigated the effects of LB1 on GBM proliferation and molecular differentiation pathways using in vitro and in vivo studies. RESULTS:The LB1 inhibited PP2A, leading to increased levels of phosphorylated Akt kinase and decreased NCoR expression, as well as dose-dependent antiproliferative activity in cultured U87 and U251 malignant glioma cells (dose range 1-10 microM). Systemic LB1 treatment (1.5 mg/kg/day for 21 days) had significant tumor antiproliferative effects in mice harboring U87 glioma xenografts (73% mean reduction in tumor volume compared with controls; p < 0.001). Moreover, a reduction in PP2A expression and activity after LB1 treatment in vivo correlated with increased Akt phosphorylation, reduced nuclear N-CoR expression and N-CoR cytoplasmic translocation, and increased accumulation of acetylated core histones, which coincided with the appearance of glial fibrillary acidic protein-expressing tumor cells. CONCLUSIONS:These findings indicate that PP2A inhibition effectively disrupts N-CoR complex function/expression and leads to cytoplasmic translocation of N-CoR with subsequent tumor cell differentiation and/or death. Therapeutic paradigms that target N-CoR function in the cancer stem cell component of malignant gliomas may have treatment utility.

journal_name

J Neurosurg

journal_title

Journal of neurosurgery

authors

Lu J,Zhuang Z,Song DK,Mehta GU,Ikejiri B,Mushlin H,Park DM,Lonser RR

doi

10.3171/2009.11.JNS091272

subject

Has Abstract

pub_date

2010-08-01 00:00:00

pages

225-33

issue

eissn

0022-3085

issn

1933-0693

journal_volume

113

pub_type

杂志文章

在线工具

The effect of a PP2A inhibitor on the nuclear receptor corepressor pathway in glioma.